Updated results of a phase 1/2 study of AU-007, a monoclonal antibody (mAb) that binds to IL-2 and inhibits CD25 binding, in patients with advanced solid tumors.

AU-007 - Aulos Biosci

https://meetings.asco.org/abstracts-presentations/233911/

Drew W. Rasco; Meredith McKean; Andrew Mark Haydon; Andrew James Weickhardt; Sophia Frentzas; Elizabeth Stephanie Ahern; John D. Powderly; Timothy Wyant; Jenny Tang; Lori Richards; Aron Knickerbocker; Inbar Amit; Yanay Ofran; James Robert Vasselli

Apr 25, 2024